Inotodiol抑制变应性鼻炎小鼠的变应性炎症
研究将40只BALB/c小鼠分为对照组、变应性鼻炎(AR)组、Inotodiol治疗组和地塞米松治疗组,每组10只。结果显示Inotodiol与地塞米松均改善揉鼻和打喷嚏症状,降低鼻灌洗液中IL-5、IL-10、IL-13及血清总IgE、特异性IgE、OVA特异性IgG1和组胺水平,并减少鼻黏膜嗜酸性粒细胞、杯状细胞和肥大细胞。结论提示Inotodiol可通过免疫调节活性帮助抑制变应性反应。
要点
- Inotodiol治疗组和地塞米松组揉鼻、打喷嚏症状均较AR组改善。
- Inotodiol组鼻灌洗液IL-5、IL-10、IL-13及血清总IgE、特异性IgE、OVA特异性IgG1、组胺均显著低于AR组。
- Inotodiol组鼻黏膜嗜酸性粒细胞、杯状细胞和肥大细胞数量明显低于AR组。
核心结论
- 结果表明Inotodiol可通过免疫调节活性帮助抑制变应性反应。
研究设计与样本
- 40只BALB/c小鼠分为4组,每组10只:对照组(CON)、磷酸盐缓冲液(PBS)治疗的AR组(AR)、Inotodiol治疗组(AR+Ino)和地塞米松治疗组(AR+Dex)。
- 检测指标包括揉鼻和打喷嚏次数、鼻灌洗液细胞因子、血清免疫球蛋白、鼻黏膜蛋白与RT-PCR及组织学分析,以及脾细胞培养细胞因子产生。
主要发现
- AR+Ino组和AR+Dex组揉鼻和打喷嚏症状较AR组改善。
- AR+Ino组和AR+Dex组鼻灌洗液IL-5、IL-10、IL-13较AR组显著降低。
- AR+Ino组和AR+Dex组鼻黏膜嗜酸性粒细胞、杯状细胞和肥大细胞数量明显低于AR组。
- AR+Ino组和AR+Dex组IL-4、IL-17A及与肥大细胞脱颗粒相关的趋化因子较AR组降低。
- AR+Ino组和AR+Dex组血清总IgE、特异性IgE、OVA特异性IgG1和组胺水平显著低于AR组;OVA刺激后AR组脾细胞IL-10和IL-13明显升高,其他组无变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inotodiol has been proven to have antitumor, antiviral, anti-inflammatory, and antiallergic properties. This study investigated the immunomodulatory capability of inotodiol in allergic rhinitis (AR) mice. METHODS: Forty BALB/c mice were divided into four groups, 10 mice each: control (CON), AR with phosphate-buffered saline (PBS) treatment (AR), inotodiol treatment (AR+Ino), and dexamethasone treatment (AR+Dex). Episodes of sneezing and nose rubbing were counted. Cytokines in nasal lavage fluid (NLF) and immunoglobulin in blood serum were measured. Nasal mucosae from each group were used for protein, reverse transcriptase-polymerase chain reaction (RT-PCR), and histological analyses. Splenocytes were cultured for evaluation of cytokine production in each group. RESULTS: Symptoms of rubbing and sneezing improved in the group of AR+Ino and AR+Dex than in the AR. NLF in the AR+Ino and AR+Dex also showed a significant decrease in interleukin (IL)-5, IL-10, and IL-13 compared to the AR. In addition, the number of eosinophils, goblet cells, and mast cells were notably lower in the nasal mucosae of the AR+Ino and AR+Dex. IL-4 and IL-17A in the AR+Ino and AR+Dex groups were decreased compared to the AR. Chemokines related to mast cell degradation were also decreased in the AR+Ino and AR+Dex groups. Total immunoglobulin (Ig)E, specific IgE and ovalbumin (OVA)-specific IgG1, and histamine levels were also significantly lower in the AR+Ino and AR+Dex groups. IL-10 and IL-13 were notably increased in the splenocytes of the AR after OVA stimulation, whereas the other groups showed no change. CONCLUSION: These results indicate inotodiol can help suppress allergic responses by immunomodulation activities.
引用
- Chung J, Choi MR, Park SK, et al. Inotodiol suppresses allergic inflammation in allergic rhinitis mice. Int Forum Allergy Rhinol. 2023. PMID: 36579475. doi:10.1002/alr.23121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。